Endovascular therapy of thoracic aneurysms: Gore TAG trial results

被引：42

作者：

Cho, Jae-Sung ^{[1
]}

Haider, Shan-e-ali ^{[1
]}

Makaroun, Michel S. ^{[1
]}

机构：

[1] Univ Pittsburgh, Sch Med, Div Vasc Surg, Pittsburgh, PA 15213 USA

来源：

SEMINARS IN VASCULAR SURGERY | 2006年 / 19卷 / 01期

关键词：

D O I：

10.1053/j.semvascsurg.2005.11.004

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Although many thoracic endografts are commercially available in Europe, only three such devices have been introduced to the United States. Gore TAG endoprosthesis was the first to enter clinical trials in the United States for treatment of descending thoracic aortic aneurysm, and gained the approval of the US Food and Drug Administration for general use in March 2005. Through clinical trials, the safety and efficacy of the Gore TAG endoprosthesis were proven and shown to be superior to those of open surgical repair. This article details the device and results of these trials.

引用

页码：18 / 24

页数：7